- A Study of the Standardization and the External Quality Assessment for Antinuclear Antibody, Anti-Double-Stranded DNA, and AntiExtractable Nuclear Antigen Antibody Testing
-
Lee J, Kim DS, Park J
- KMID: 2527801
- Lab Med Qual Assur.
- 2022 Mar;44(1):21-28.
- doi: 10.15263/jlmqa.2022.44.1.21
Autoantibodies to nuclear antigens (antinuclear antibodies, ANAs), doublestranded DNA (dsDNA), and extractable nuclear antigens (ENAs) are useful for the early diagnosis and appropriate treatment of autoimmune diseases. This study aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Application of Geometric Mean Criteria for AntiBlood Group Antibody Proficiency Testing in the Korean External Quality Assurance Program
-
Yang JJ, Youk HJ, Chung Y, Kim H, Hwang SH, Oh HB, Ko DH
- KMID: 2527805
- Lab Med Qual Assur.
- 2022 Mar;44(1):48-54.
- doi: 10.15263/jlmqa.2022.44.1.48
Background: The geometric mean criteria (GC) is an alternative for assessing proficiency testing (PT) acceptability. A recent study applied GC to the PT results provided by the College of American... -
- CITED
-
- Close
- SHARE
-
- Close
- Annual Report of the Korean External Quality Assessment Service on Urinalysis and Fecal Occult Blood Testing (2020)
-
Jeon CH, Lee AJ, Bae YC
- KMID: 2527799
- Lab Med Qual Assur.
- 2022 Mar;44(1):1-9.
- doi: 10.15263/jlmqa.2022.44.1.1
In 2020, external quality assessment trials for urinalysis and fecal occult blood (FOB) testing were conducted using data from 1,696 participants. Urine chemistry tests were performed three times, and urine... -
- CITED
-
- Close
- SHARE
-
- Close
- Annual Report of the Korean External Quality Assessment Service on Transfusion Medicine (2021)
-
Youk HJ, Kim JS, Yang JJ, Kim H, Ko DH
- KMID: 2527800
- Lab Med Qual Assur.
- 2022 Mar;44(1):10-20.
- doi: 10.15263/jlmqa.2022.44.1.10
This report summarizes the 2021 survey results of the external quality assessment (EQA) scheme for the transfusion medicine program (TMP) in Korea. Proficiency testing materials were prepared at the Asan... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Reliability of Automated Colistin Susceptibility Assays of Pseudomonas aeruginosa
-
Kim YA, Kim J, Son YJ, Lee SS
- KMID: 2527803
- Lab Med Qual Assur.
- 2022 Mar;44(1):36-39.
- doi: 10.15263/jlmqa.2022.44.1.36
Background: With the increase in multidrug-resistant (MDR) gram-negative rods, colistin treatment is increasingly required. Reliable susceptibility testing is important for managing infectious patients with MDR Pseudomonas aeruginosa. This study evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation to Reduce Delivery Delay Rate of Proficiency Test Materials and Maintaining Materials in Proper Temperature Ranges during Delivery
-
Ahn S, Oh Y, Chun S, Min WK
- KMID: 2527806
- Lab Med Qual Assur.
- 2022 Mar;44(1):55-60.
- doi: 10.15263/jlmqa.2022.44.1.55
Background: The Korean Association of External Quality Assessment Service provides proficiency test (PT) materials through a logistics company. We investigated the delivery times of PT materials in 2020 and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Clinical Utility of Urine Sediments
-
Lee AJ, Kim SG, Jeon CH
- KMID: 2527802
- Lab Med Qual Assur.
- 2022 Mar;44(1):29-35.
- doi: 10.15263/jlmqa.2022.44.1.29
Background: In this study, after reporting the urine sediment, the clinical utility of the results was analyzed to broaden the clinical usefulness of urine sediment. Methods: This study included 114 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Cross-Reactivity of Disease-Specific Antibody Assays for the Detection of Current Infections: With Potentially Interfering Substances of Other Infections
-
Gong DH, Kim SH, Kim HJ, Lee A, Han MS
- KMID: 2527804
- Lab Med Qual Assur.
- 2022 Mar;44(1):40-47.
- doi: 10.15263/jlmqa.2022.44.1.40
Background: Current infections are frequently diagnosed based on positive immunoglobulin (Ig) M results, although false positivity can occur. We evaluated cross-reactivity among infectious antibody (Ab) assays. Methods: A total of 167... -
- CITED
-
- Close
- SHARE
-
- Close
